BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28172817)

  • 1. Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression.
    Hoskins JW; Ibrahim A; Emmanuel MA; Manmiller SM; Wu Y; O'Neill M; Jia J; Collins I; Zhang M; Thomas JV; Rost LM; Das S; Parikh H; Haake JM; Matters GL; Kurtz RC; Bamlet WR; Klein A; Stolzenberg-Solomon R; Wolpin BM; Yarden R; Wang Z; Smith J; Olson SH; Andresson T; Petersen GM; Amundadottir LT
    Hum Mol Genet; 2016 Nov; 25(21):4726-4738. PubMed ID: 28172817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk.
    Parikh H; Jia J; Zhang X; Chung CC; Jacobs KB; Yeager M; Boland J; Hutchinson A; Burdett L; Hoskins J; Risch HA; Stolzenberg-Solomon RZ; Chanock SJ; Wolpin BM; Petersen GM; Fuchs CS; Hartge P; Amundadottir L
    Pancreas; 2013 Mar; 42(2):209-15. PubMed ID: 23295781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DIS3 shapes the RNA polymerase II transcriptome in humans by degrading a variety of unwanted transcripts.
    Szczepińska T; Kalisiak K; Tomecki R; Labno A; Borowski LS; Kulinski TM; Adamska D; Kosinska J; Dziembowski A
    Genome Res; 2015 Nov; 25(11):1622-33. PubMed ID: 26294688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148.
    Fang J; Jia J; Makowski M; Xu M; Wang Z; Zhang T; Hoskins JW; Choi J; Han Y; Zhang M; Thomas J; Kovacs M; Collins I; Dzyadyk M; Thompson A; O'Neill M; Das S; Lan Q; Koster R; ; ; ; Stolzenberg-Solomon RS; Kraft P; Wolpin BM; Jansen PWTC; Olson S; McGlynn KA; Kanetsky PA; Chatterjee N; Barrett JH; Dunning AM; Taylor JC; Newton-Bishop JA; Bishop DT; Andresson T; Petersen GM; Amos CI; Iles MM; Nathanson KL; Landi MT; Vermeulen M; Brown KM; Amundadottir LT
    Nat Commun; 2017 May; 8():15034. PubMed ID: 28447668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterising
    Zhang M; Lykke-Andersen S; Zhu B; Xiao W; Hoskins JW; Zhang X; Rost LM; Collins I; Bunt MV; Jia J; Parikh H; Zhang T; Song L; Jermusyk A; Chung CC; Zhu B; Zhou W; Matters GL; Kurtz RC; Yeager M; Jensen TH; Brown KM; Ongen H; Bamlet WR; Murray BA; McCarthy MI; Chanock SJ; Chatterjee N; Wolpin BM; Smith JP; Olson SH; Petersen GM; Shi J; Amundadottir L
    Gut; 2018 Mar; 67(3):521-533. PubMed ID: 28634199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exonuclease domain mutants of yeast DIS3 display genome instability.
    Milbury KL; Paul B; Lari A; Fowler C; Montpetit B; Stirling PC
    Nucleus; 2019 Dec; 10(1):21-32. PubMed ID: 30724665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
    Zhu DL; Chen XF; Hu WX; Dong SS; Lu BJ; Rong Y; Chen YX; Chen H; Thynn HN; Wang NN; Guo Y; Yang TL
    J Bone Miner Res; 2018 Jul; 33(7):1335-1346. PubMed ID: 29528523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.
    de Groen FL; Krijgsman O; Tijssen M; Vriend LE; Ylstra B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
    Genes Chromosomes Cancer; 2014 Apr; 53(4):339-48. PubMed ID: 24478024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias.
    Lionetti M; Barbieri M; Todoerti K; Agnelli L; Fabris S; Tonon G; Segalla S; Cifola I; Pinatel E; Tassone P; Musto P; Baldini L; Neri A
    Oncotarget; 2015 Sep; 6(28):26129-41. PubMed ID: 26305418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
    Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
    Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncoding RNA processing by DIS3 regulates chromosomal architecture and somatic hypermutation in B cells.
    Laffleur B; Lim J; Zhang W; Chen Y; Pefanis E; Bizarro J; Batista CR; Wu L; Economides AN; Wang J; Basu U
    Nat Genet; 2021 Feb; 53(2):230-242. PubMed ID: 33526923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 3' to 5' Exoribonuclease DIS3: From Structure and Mechanisms to Biological Functions and Role in Human Disease.
    Robinson SR; Oliver AW; Chevassut TJ; Newbury SF
    Biomolecules; 2015 Jul; 5(3):1515-39. PubMed ID: 26193331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.
    Petersen GM; Amundadottir L; Fuchs CS; Kraft P; Stolzenberg-Solomon RZ; Jacobs KB; Arslan AA; Bueno-de-Mesquita HB; Gallinger S; Gross M; Helzlsouer K; Holly EA; Jacobs EJ; Klein AP; LaCroix A; Li D; Mandelson MT; Olson SH; Risch HA; Zheng W; Albanes D; Bamlet WR; Berg CD; Boutron-Ruault MC; Buring JE; Bracci PM; Canzian F; Clipp S; Cotterchio M; de Andrade M; Duell EJ; Gaziano JM; Giovannucci EL; Goggins M; Hallmans G; Hankinson SE; Hassan M; Howard B; Hunter DJ; Hutchinson A; Jenab M; Kaaks R; Kooperberg C; Krogh V; Kurtz RC; Lynch SM; McWilliams RR; Mendelsohn JB; Michaud DS; Parikh H; Patel AV; Peeters PH; Rajkovic A; Riboli E; Rodriguez L; Seminara D; Shu XO; Thomas G; Tjønneland A; Tobias GS; Trichopoulos D; Van Den Eeden SK; Virtamo J; Wactawski-Wende J; Wang Z; Wolpin BM; Yu H; Yu K; Zeleniuch-Jacquotte A; Fraumeni JF; Hoover RN; Hartge P; Chanock SJ
    Nat Genet; 2010 Mar; 42(3):224-8. PubMed ID: 20101243
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ohguchi Y; Ohguchi H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility.
    Baskin R; Woods NT; Mendoza-Fandiño G; Forsyth P; Egan KM; Monteiro AN
    Sci Rep; 2015 Nov; 5():17367. PubMed ID: 26610392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
    Tang H; Wei P; Chang P; Li Y; Yan D; Liu C; Hassan M; Li D
    Int J Cancer; 2017 Aug; 141(4):678-686. PubMed ID: 28470677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ribonuclease Dis3 is an essential regulator of the developmental transcriptome.
    Hou D; Ruiz M; Andrulis ED
    BMC Genomics; 2012 Aug; 13():359. PubMed ID: 22853036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ribonuclease DIS3 promotes let-7 miRNA maturation by degrading the pluripotency factor LIN28B mRNA.
    Segalla S; Pivetti S; Todoerti K; Chudzik MA; Giuliani EC; Lazzaro F; Volta V; Lazarevic D; Musco G; Muzi-Falconi M; Neri A; Biffo S; Tonon G
    Nucleic Acids Res; 2015 May; 43(10):5182-93. PubMed ID: 25925570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.
    Zhang M; Wang Z; Obazee O; Jia J; Childs EJ; Hoskins J; Figlioli G; Mocci E; Collins I; Chung CC; Hautman C; Arslan AA; Beane-Freeman L; Bracci PM; Buring J; Duell EJ; Gallinger S; Giles GG; Goodman GE; Goodman PJ; Kamineni A; Kolonel LN; Kulke MH; Malats N; Olson SH; Sesso HD; Visvanathan K; White E; Zheng W; Abnet CC; Albanes D; Andreotti G; Brais L; Bueno-de-Mesquita HB; Basso D; Berndt SI; Boutron-Ruault MC; Bijlsma MF; Brenner H; Burdette L; Campa D; Caporaso NE; Capurso G; Cavestro GM; Cotterchio M; Costello E; Elena J; Boggi U; Gaziano JM; Gazouli M; Giovannucci EL; Goggins M; Gross M; Haiman CA; Hassan M; Helzlsouer KJ; Hu N; Hunter DJ; Iskierka-Jazdzewska E; Jenab M; Kaaks R; Key TJ; Khaw KT; Klein EA; Kogevinas M; Krogh V; Kupcinskas J; Kurtz RC; Landi MT; Landi S; Le Marchand L; Mambrini A; Mannisto S; Milne RL; Neale RE; Oberg AL; Panico S; Patel AV; Peeters PH; Peters U; Pezzilli R; Porta M; Purdue M; Quiros JR; Riboli E; Rothman N; Scarpa A; Scelo G; Shu XO; Silverman DT; Soucek P; Strobel O; Sund M; Małecka-Panas E; Taylor PR; Tavano F; Travis RC; Thornquist M; Tjønneland A; Tobias GS; Trichopoulos D; Vashist Y; Vodicka P; Wactawski-Wende J; Wentzensen N; Yu H; Yu K; Zeleniuch-Jacquotte A; Kooperberg C; Risch HA; Jacobs EJ; Li D; Fuchs C; Hoover R; Hartge P; Chanock SJ; Petersen GM; Stolzenberg-Solomon RS; Wolpin BM; Kraft P; Klein AP; Canzian F; Amundadottir LT
    Oncotarget; 2016 Oct; 7(41):66328-66343. PubMed ID: 27579533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma.
    Weißbach S; Langer C; Puppe B; Nedeva T; Bach E; Kull M; Bargou R; Einsele H; Rosenwald A; Knop S; Leich E
    Br J Haematol; 2015 Apr; 169(1):57-70. PubMed ID: 25521164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.